Treatment Registry

Company

REMEVi

Recorded offers and program terms appear below. Check eligibility, billing periods and separate fees before comparing totals.

Published by Treatment Registry · Latest research

  • 3 programs
  • 2 identified molecules
  • 6 readings

Read from remevihealth.com; latest program check October 2026. Individual programs and sources may have earlier verification dates.

Go to REMEVi

Visit REMEVi

We earn nothing from this link. It opens REMEVi's website without a paid referral.

Terms

Pharmacy

Not disclosed

Across recorded programs · Evidence: October 2026

Membership

None. “No separate membership fee.”

Across recorded programs · Evidence: October 2026

Consultation fee

Included in program price; itemized amount not published. Clinical evaluation and follow-up are included in the GLP-1 plan price; questionnaire free.

Across recorded programs · Evidence: October 2026

States

All states except Louisiana

Across recorded programs · Evidence: October 2026

Programs

More columns to the right? Scroll across the table to see all details.

EntryProgramFormRecorded price
with its payment basis
Link
EntryTR-0589ProgramCompounded semaglutideFormInjection · device not recordedRecorded price$199
Per 4 weeks · Short plan — 4 weeks, advertised “Monthly”

Prescription and eligibility required. Published $199 charge covers 1 four-week cycle; the public selector renews every 4 weeks. Marketing “month” means 28 days, not a calendar month. Cancellation notice and refund limits apply.

Record
EntryTR-0590ProgramCompounded tirzepatideFormInjection · device not recordedRecorded price$269
Per 4 weeks · Short plan — 4 weeks, advertised “Monthly”

Prescription and eligibility required. Published $269 charge covers 1 four-week cycle; the public selector renews every 4 weeks. Marketing “month” means 28 days, not a calendar month. Cancellation notice and refund limits apply.

Record
EntryTR-0591ProgramCompounded semaglutideFormOral tabletRecorded price$249
Per 4 weeks · Short plan — 4 weeks, advertised “Monthly”

Prescription and eligibility required. Published $249 charge covers 1 four-week cycle; the public selector renews every 4 weeks. Marketing “month” means 28 days, not a calendar month. Cancellation notice and refund limits apply.

Record

Notes

Pricing details, service terms and questions to confirm before enrolling.

October 2026

  1. 1. REMEVi’s plan month is four weeks (28 days), not a calendar month. The current public plan selector explicitly renews short plans every four weeks, three-cycle prepaid plans every 12 weeks and six-cycle plans every 24 weeks. Published upfront totals are recorded directly; the advertised monthly equivalents are not calendar-month bills. One how-it-works summary calls the longest renewal “every 6 months”; the explicit current pricing selector and its billing FAQ supply the more precise cycle. Each GLP-1 plan includes clinical evaluation and follow-up, prescribed medication, required program labs, applicable supplies, shipping and bilingual support, with no separate membership or dose upcharge. Cancellation requests must arrive at least 72 hours before billing to avoid the next charge. A full refund within the first 72 hours requires that no service has been provided; medical disqualification and unshipped prepaid periods have separate refund rules. Care is available in 49 states and Washington, DC, excluding Louisiana, subject to state-licensed clinical review. The pharmacy directory says its network list was last confirmed in July 2026; the current FAQ names RedRock, Health Warehouse, Precision Medicine and Triad Rx, but the patient’s assigned pharmacy must be confirmed. Intake starts with an online questionnaire; a clinician may require more information, labs or a live visit.

September 2026

  1. 2. Explicitly no membership fee, repeatedly: 'We sell medicine not memberships' and a comparison table showing '$79-$149/mo Membership fees / What most programs add on top' crossed out to $0. All prices are flat regardless of dose per the site's own claim. The homepage HTML contains an internal marketing/analytics comment about a Google Tag Manager cutover embedded oddly in the page source; this is developer/marketing documentation, not visible reader-facing text, and was not treated as a fact or instruction.

Understand the terms

Before you act

Cite this

Treatment Registry. (2026). REMEVi: recorded programs and prices. Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/remevi